These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 34592364
21. A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds. Garbacz G, Kołodziej B, Koziolek M, Weitschies W, Klein S. Eur J Pharm Sci; 2014 Jan 23; 51():224-31. PubMed ID: 24095865 [Abstract] [Full Text] [Related]
22. In vitro prediction of in vivo absorption of ibuprofen from suspensions through rational choice of dissolution conditions. Hofmann M, García MA, Al-Gousous J, Ruiz-Picazo A, Thieringer F, Nguyen MA, Månsson W, Galle PR, Langguth P. Eur J Pharm Biopharm; 2020 Apr 23; 149():229-237. PubMed ID: 32112894 [Abstract] [Full Text] [Related]
23. Dissolution properties of co-amorphous drug-amino acid formulations in buffer and biorelevant media. Heikkinen AT, DeClerck L, Löbmann K, Grohganz H, Rades T, Laitinen R. Pharmazie; 2015 Jul 23; 70(7):452-7. PubMed ID: 26373205 [Abstract] [Full Text] [Related]
24. Drug Crystal Precipitation in Biorelevant Bicarbonate Buffer: A Well-Controlled Comparative Study with Phosphate Buffer. Yamamoto H, Sugano K. Mol Pharm; 2024 Jun 03; 21(6):2854-2864. PubMed ID: 38718215 [Abstract] [Full Text] [Related]
25. Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3. Fuchs A, Leigh M, Kloefer B, Dressman JB. Eur J Pharm Biopharm; 2015 Aug 03; 94():229-40. PubMed ID: 26032292 [Abstract] [Full Text] [Related]
26. Selection of In Vivo Predictive Dissolution Media Using Drug Substance and Physiological Properties. Mudie DM, Samiei N, Marshall DJ, Amidon GE, Bergström CAS. AAPS J; 2020 Jan 27; 22(2):34. PubMed ID: 31989343 [Abstract] [Full Text] [Related]
27. Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products. Liu F, Merchant HA, Kulkarni RP, Alkademi M, Basit AW. Eur J Pharm Biopharm; 2011 May 27; 78(1):151-7. PubMed ID: 21255647 [Abstract] [Full Text] [Related]
28. In vivo predictive dissolution: transport analysis of the CO2 , bicarbonate in vivo buffer system. Krieg BJ, Taghavi SM, Amidon GL, Amidon GE. J Pharm Sci; 2014 Nov 27; 103(11):3473-3490. PubMed ID: 25212721 [Abstract] [Full Text] [Related]
29. Dissolution Profiles of Oral Disintegrating Tablet with Taste Masking Granule Polymer Coating in Biorelevant Bicarbonate Buffer. Higashino M, Sugano K. Chem Pharm Bull (Tokyo); 2024 Nov 27; 72(3):298-302. PubMed ID: 38479857 [Abstract] [Full Text] [Related]
30. Predicting the gastrointestinal behaviour of modified-release products: utility of a novel dynamic dissolution test apparatus involving the use of bicarbonate buffers. Merchant HA, Goyanes A, Parashar N, Basit AW. Int J Pharm; 2014 Nov 20; 475(1-2):585-91. PubMed ID: 25195730 [Abstract] [Full Text] [Related]
31. Assessing the influence of media composition and ionic strength on drug release from commercial immediate-release and enteric-coated aspirin tablets. Karkossa F, Klein S. J Pharm Pharmacol; 2017 Oct 20; 69(10):1327-1340. PubMed ID: 28703304 [Abstract] [Full Text] [Related]
32. An automated system for monitoring and regulating the pH of bicarbonate buffers. Garbacz G, Kołodziej B, Koziolek M, Weitschies W, Klein S. AAPS PharmSciTech; 2013 Jun 20; 14(2):517-22. PubMed ID: 23468339 [Abstract] [Full Text] [Related]
33. Importance of critical micellar concentration for the prediction of solubility enhancement in biorelevant media. Ottaviani G, Wendelspiess S, Alvarez-Sánchez R. Mol Pharm; 2015 Apr 06; 12(4):1171-9. PubMed ID: 25665011 [Abstract] [Full Text] [Related]
34. Mechanistic understanding of underperforming enteric coated products: Opportunities to add clinical relevance to the dissolution test. Amaral Silva D, Davies NM, Doschak MR, Al-Gousous J, Bou-Chacra N, Löbenberg R. J Control Release; 2020 Sep 10; 325():323-334. PubMed ID: 32649973 [Abstract] [Full Text] [Related]
35. Mechanistic analysis and experimental verification of bicarbonate-controlled enteric coat dissolution: Potential in vivo implications. Al-Gousous J, Ruan H, Blechar JA, Sun KX, Salehi N, Langguth P, Job NM, Lipka E, Loebenberg R, Bermejo M, Amidon GE, Amidon GL. Eur J Pharm Biopharm; 2019 Jun 10; 139():47-58. PubMed ID: 30872012 [Abstract] [Full Text] [Related]
36. Real-time dissolution behavior of furosemide in biorelevant media as determined by UV imaging. Gordon S, Naelapää K, Rantanen J, Selen A, Müllertz A, Østergaard J. Pharm Dev Technol; 2013 Jun 10; 18(6):1407-16. PubMed ID: 23136844 [Abstract] [Full Text] [Related]
37. Dissolution Profiles of Poorly Soluble Drug Salts in Bicarbonate Buffer. Sakamoto A, Sugano K. Pharm Res; 2023 Apr 10; 40(4):989-998. PubMed ID: 37024757 [Abstract] [Full Text] [Related]
38. Toward Mechanistic Design of Surrogate Buffers for Dissolution Testing of pH-Dependent Drug Delivery Systems. Blechar JA, Al-Gousous J, Wilhelmy C, Postina AM, Getto M, Langguth P. Pharmaceutics; 2020 Dec 10; 12(12):. PubMed ID: 33321933 [Abstract] [Full Text] [Related]
39. Biorelevant dissolution testing of a weak base: Interlaboratory reproducibility and investigation of parameters controlling in vitro precipitation. Berben P, Ashworth L, Beato S, Bevernage J, Bruel JL, Butler J, Dressman J, Schäfer K, Hutchins P, Klumpp L, Mann J, Nicolai J, Ojala K, Patel S, Powell S, Rosenblatt K, Tomaszewska I, Williams J, Augustijns P. Eur J Pharm Biopharm; 2019 Jul 10; 140():141-148. PubMed ID: 31051249 [Abstract] [Full Text] [Related]
40. Dissolution behavior of various drugs in different FaSSIF versions. Klumpp L, Leigh M, Dressman J. Eur J Pharm Sci; 2020 Jan 15; 142():105138. PubMed ID: 31704344 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]